Cite Filings / AMLX / 0000950170-23-015261

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Amylyx Pharmaceuticals, Inc. Filed 2023-04-27 Acc 0000950170-23-015261

Documents 1

DEF 14A Proxy Statement , amlx-def14a-2023-proxy.htm

Around this filing

2024-04-24 DEF 14A Proxy Statement
2023-04-27 ARS Annual Report to Security Holders
2023-04-27 DEFA14A Proxy Materials
2023-04-27 DEF 14A Proxy Statement
2023-04-26 4/A Chief Financial Officer acquired 19,482 shares (conversion)
2023-04-26 3/A 3/A
2022-04-29 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading amlx-def14a-2023-proxy.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…